Login / Signup

Decision impact studies, evidence of clinical utility for genomic assays in cancer: A scoping review.

Gillian ParkerSarah HunterSamer GhaziRobin Z HayeemsFrancois RousseauFiona A Miller
Published in: PloS one (2023)
This scoping review is a first step in understanding the evolution and uses of decision impact studies and their influence on the integration of emerging genomic technologies in cancer care. The results imply that DIS are positioned to provide evidence of clinical utility and impact clinical practice and reimbursement decision-making in cancer care. Systematic review registration: Open Science Framework osf.io/hm3jr.
Keyphrases